Charles River Laboratories International Aktie
142,80
EUR
+5,70
EUR
+4,16
%
165,26
USD
-0,68
USD
-0,41
%
Werbung
Charles River Laboratories International Aktie Analyse
| 14.12.18 | Charles River Laboratories International Buy | Deutsche Bank AG | |
| 26.04.16 | Charles River Laboratories International Buy | Gabelli & Co | |
| 13.05.10 | Charles River Laboratories International kaufen | Robert W. Baird & Co. Incorporated | |
| 02.05.07 | Charles River Laboratories International outperform | Robert W. Baird | |
| 17.04.07 | Charles River Laboratories International overweight | Lehman Brothers | |
| 15.02.07 | Charles River Laboratories International buy | Jefferies & Co | |
| 04.05.06 | Charles River Laboratories International overweight | Lehman Brothers | |
| 04.05.06 | Charles River Laboratories International Overweight | Lehman Brothers | |
|
Werbung
|
|||
| 13.12.05 | Charles River Laboratories International | Biotech-Report | |
| 27.10.05 | Charles River Laboratories International outperform | Goldman Sachs | |
| 27.10.05 | Charles River Laboratories International Outperform | Goldman Sachs | |
Werbung
Werbung